Illegal drug prices rise.

Woodznutz

Diamond Member
Joined
Dec 9, 2021
Messages
33,141
Reaction score
16,682
Points
1,788
Though unintended the price of some street drugs have risen beyond the reach of many addicts. Many health officials are decrying Trump's war on drugs as shortages may exacerbate treatment efforts. Here's a somewhat "tongue-in-cheek" take on it.

 
Though unintended the price of some street drugs have risen beyond the reach of many addicts. Many health officials are decrying Trump's war on drugs as shortages may exacerbate treatment efforts. Here's a somewhat "tongue-in-cheek" take on it.

Horseshit! He is creating a problem with legal drugs

AI Overview



There is
no evidence of a general street drug shortage related to Donald Trump or his policies. In fact, global cocaine production is at record highs, and while U.S. overdose deaths have decreased, supply reduction efforts have generally not been shown to create long-term shortages of illicit substances.
Key facts regarding the illicit drug supply in the U.S. include:
  • Abundant Supply: Despite law enforcement efforts, the overall supply of illicit drugs like fentanyl, methamphetamine, and cocaine remains high, driven by powerful transnational criminal organizations and high profitability.
  • Fentanyl Purity and Potency: The U.S. Drug Enforcement Administration (DEA) has noted a decrease in the purity and potentially lethal dose concentration of seized fentanyl pills and powder in FY 2025. However, this indicates a change in cartel operations (e.g., more domestic pill production) rather than a comprehensive shortage, and experts note that supply reduction alone has not been effective at curbing demand.
  • Policy Focus: The Trump administration's approach has emphasized an enforcement-heavy, supply-side strategy focused on border interdiction and targeting cartels, rather than demand-reduction efforts. Experts argue that such an approach is often ineffective in the long term, as market forces lead traffickers to smuggle cheaper, more potent alternatives (like fentanyl).
  • Pharmaceutical Shortages: The U.S. is currently experiencing a record number of shortages for legal, prescription medications due to manufacturing problems, supply chain disruptions, and regulatory issues. Proposed tariffs by the Trump administration on imported pharmaceuticals could exacerbate these specific, legal drug shortages.
The idea that political policies have caused a shortage of street drugs is not supported by current data on the illicit market.
 
Horseshit! He is creating a problem with legal drugs

AI Overview



There is
no evidence of a general street drug shortage related to Donald Trump or his policies. In fact, global cocaine production is at record highs, and while U.S. overdose deaths have decreased, supply reduction efforts have generally not been shown to create long-term shortages of illicit substances.
Key facts regarding the illicit drug supply in the U.S. include:
  • Abundant Supply: Despite law enforcement efforts, the overall supply of illicit drugs like fentanyl, methamphetamine, and cocaine remains high, driven by powerful transnational criminal organizations and high profitability.
  • Fentanyl Purity and Potency: The U.S. Drug Enforcement Administration (DEA) has noted a decrease in the purity and potentially lethal dose concentration of seized fentanyl pills and powder in FY 2025. However, this indicates a change in cartel operations (e.g., more domestic pill production) rather than a comprehensive shortage, and experts note that supply reduction alone has not been effective at curbing demand.
  • Policy Focus: The Trump administration's approach has emphasized an enforcement-heavy, supply-side strategy focused on border interdiction and targeting cartels, rather than demand-reduction efforts. Experts argue that such an approach is often ineffective in the long term, as market forces lead traffickers to smuggle cheaper, more potent alternatives (like fentanyl).
  • Pharmaceutical Shortages: The U.S. is currently experiencing a record number of shortages for legal, prescription medications due to manufacturing problems, supply chain disruptions, and regulatory issues. Proposed tariffs by the Trump administration on imported pharmaceuticals could exacerbate these specific, legal drug shortages.
The idea that political policies have caused a shortage of street drugs is not supported by current data on the illicit market.
You are so full of shit....I remember when a huge heroin bust took place both in NYC and in Richmond back in the 70s. It had MCV (Richmond) full of addicts coping with withdraw symptoms.

They packed the halls so don't give us a raft of shit about what cutting off supply does.
 
Last edited:
Horseshit! He is creating a problem with legal drugs

AI Overview



There is
no evidence of a general street drug shortage related to Donald Trump or his policies. In fact, global cocaine production is at record highs, and while U.S. overdose deaths have decreased, supply reduction efforts have generally not been shown to create long-term shortages of illicit substances.
Key facts regarding the illicit drug supply in the U.S. include:
  • Abundant Supply: Despite law enforcement efforts, the overall supply of illicit drugs like fentanyl, methamphetamine, and cocaine remains high, driven by powerful transnational criminal organizations and high profitability.
  • Fentanyl Purity and Potency: The U.S. Drug Enforcement Administration (DEA) has noted a decrease in the purity and potentially lethal dose concentration of seized fentanyl pills and powder in FY 2025. However, this indicates a change in cartel operations (e.g., more domestic pill production) rather than a comprehensive shortage, and experts note that supply reduction alone has not been effective at curbing demand.
  • Policy Focus: The Trump administration's approach has emphasized an enforcement-heavy, supply-side strategy focused on border interdiction and targeting cartels, rather than demand-reduction efforts. Experts argue that such an approach is often ineffective in the long term, as market forces lead traffickers to smuggle cheaper, more potent alternatives (like fentanyl).
  • Pharmaceutical Shortages: The U.S. is currently experiencing a record number of shortages for legal, prescription medications due to manufacturing problems, supply chain disruptions, and regulatory issues. Proposed tariffs by the Trump administration on imported pharmaceuticals could exacerbate these specific, legal drug shortages.
The idea that political policies have caused a shortage of street drugs is not supported by current data on the illicit market.
You need to cite your sources, captain.
 
You need to cite your sources, captain.
This tariff increase translates into higher drug prices in the U.S., estimated at several hundred dollars more per family annually. Such cost increases threaten patient access to care, especially for generic and biosimilar medicines essential in oncology and other critical areas.Nov 8, 2025

The Impact of U.S. Tariffs on the Pharmaceutical Industry and ...​

 
Horseshit! He is creating a problem with legal drugs

AI Overview



There is
no evidence of a general street drug shortage related to Donald Trump or his policies. In fact, global cocaine production is at record highs, and while U.S. overdose deaths have decreased, supply reduction efforts have generally not been shown to create long-term shortages of illicit substances.
Key facts regarding the illicit drug supply in the U.S. include:
  • Abundant Supply: Despite law enforcement efforts, the overall supply of illicit drugs like fentanyl, methamphetamine, and cocaine remains high, driven by powerful transnational criminal organizations and high profitability.
  • Fentanyl Purity and Potency: The U.S. Drug Enforcement Administration (DEA) has noted a decrease in the purity and potentially lethal dose concentration of seized fentanyl pills and powder in FY 2025. However, this indicates a change in cartel operations (e.g., more domestic pill production) rather than a comprehensive shortage, and experts note that supply reduction alone has not been effective at curbing demand.
  • Policy Focus: The Trump administration's approach has emphasized an enforcement-heavy, supply-side strategy focused on border interdiction and targeting cartels, rather than demand-reduction efforts. Experts argue that such an approach is often ineffective in the long term, as market forces lead traffickers to smuggle cheaper, more potent alternatives (like fentanyl).
  • Pharmaceutical Shortages: The U.S. is currently experiencing a record number of shortages for legal, prescription medications due to manufacturing problems, supply chain disruptions, and regulatory issues. Proposed tariffs by the Trump administration on imported pharmaceuticals could exacerbate these specific, legal drug shortages.
The idea that political policies have caused a shortage of street drugs is not supported by current data on the illicit market.
You missed the point. Although drug supplies remain high the losses due to interdiction are being made up for by higher street prices. The cartels 'oversupply' the market purposely. This allows street dealers to expand their customer base beyond their 'regulars'.
 
That's not a citation. Did you people even go to school?

President Trump has recently floated the idea of imposing tariffs of up to 250 percent on pharmaceuticals, with the intention of shifting pharmaceutical production to the US. These tariffs would not only drive drug prices higher but could also lead to shortages and reduce long-run drug innovation.
 

President Trump has recently floated the idea of imposing tariffs of up to 250 percent on pharmaceuticals, with the intention of shifting pharmaceutical production to the US. These tariffs would not only drive drug prices higher but could also lead to shortages and reduce long-run drug innovation.
Ever negotiate? Know how it works?
 

President Trump has recently floated the idea of imposing tariffs of up to 250 percent on pharmaceuticals, with the intention of shifting pharmaceutical production to the US. These tariffs would not only drive drug prices higher but could also lead to shortages and reduce long-run drug innovation.
Although prescription meds are increasing among seniors, over 80 percent have prescription drug coverage.
 
Back
Top Bottom